What is the recommended dosage and management for an epinephrine (adrenaline) drip in a patient with severe hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Drip for Severe Hypotension Management

For severe hypotension, an epinephrine drip should be prepared by adding 1 mg (1 mL) of epinephrine to 100 mL of normal saline, creating a 10 mcg/mL solution, with an initial infusion rate of 0.05-2 mcg/kg/min, titrated to achieve a target mean arterial pressure (MAP) of 65 mmHg. 1, 2

Preparation Options

Standard Preparation Method

  • Add 1 mg (1 mL) of epinephrine to 100 mL of normal saline or D5W to create a 10 mcg/mL solution 1, 2
  • Alternative preparation: Add 1 mg (1 mL) of epinephrine to 250 mL of D5W to create a 4 mcg/mL solution 3

Administration Route

  • Administer through a large vein whenever possible 2
  • Avoid catheter tie-in techniques which may cause stasis and increased local concentration of the drug 2
  • Avoid veins of the leg in elderly patients or those with occlusive vascular diseases 2

Dosing Protocol

Initial Dosing

  • Start at 0.05-0.5 mcg/kg/min 1, 2
  • Titrate up to 2 mcg/kg/min based on blood pressure response 2
  • For pediatric patients: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution; maximum 0.3 mg) 3
  • Alternative pediatric dosing using "rule of 6": 0.6 × weight (kg) = mg diluted to 100 mL saline; then 1 mL/hr delivers 0.1 mcg/kg/min 3

Titration

  • Adjust dosage every 10-15 minutes in increments of 0.05-0.2 mcg/kg/min to achieve desired MAP of 65 mmHg 1, 2
  • If inadequate response after 10 minutes, consider doubling the dose 1
  • After hemodynamic stabilization, wean incrementally over 12-24 hours, decreasing doses every 30 minutes 2

Monitoring Requirements

Essential Monitoring

  • Continuous electrocardiographic monitoring 3, 1
  • Frequent blood pressure measurements (every minute if continuous monitoring unavailable) 3
  • Continuous arterial blood pressure monitoring when available 1
  • Assessment of tissue perfusion markers (lactate levels, urine output, capillary refill time) 1
  • Vigilant monitoring of infusion site for extravasation 1

Management of Refractory Hypotension

Escalation Strategy

  • If no response to epinephrine, consider:
    • Adding vasopressin (up to 0.03 U/min) as a second agent 1
    • Additional fluid administration (up to 20-30 mL/kg) 3, 1
    • For patients on beta-blockers: Consider IV glucagon (1-5 mg) 3, 1

Special Situations

  • For patients with cardiac arrest during anaphylaxis:
    • Higher doses may be required: 1-3 mg (1:10,000 dilution) IV over 3 minutes, followed by 3-5 mg IV over 3 minutes, then 4-10 mg/min infusion 3
    • For children with cardiac arrest: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) every 3-5 minutes 3

Complications and Management

Potential Complications

  • Acute severe hypertension 1, 2
  • Pulmonary edema (potentially fatal) 1
  • Cardiac arrhythmias and myocardial ischemia (particularly in patients with underlying heart disease) 1, 2
  • Tissue necrosis from extravasation 1, 2
  • Oliguria or renal impairment 1

Management of Complications

  • For extravasation: Infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the affected site 1
  • For arrhythmias: Consider reducing infusion rate and treating the specific arrhythmia 1
  • Avoid mixing epinephrine with alkaline solutions like sodium bicarbonate (causes inactivation) 1

Important Cautions

  • Epinephrine should be used with caution in patients with ischemic heart disease 1, 2
  • Avoid in patients with mesenteric or peripheral vascular thrombosis 1
  • Correct hypovolemia before administering epinephrine 1
  • Drug interactions to monitor: alpha blockers, vasodilators, beta blockers, tricyclic antidepressants, MAO inhibitors 2

By following this protocol for epinephrine administration in severe hypotension, clinicians can optimize outcomes while minimizing potential complications. Continuous monitoring and appropriate titration are essential components of successful management.

References

Guideline

Hypotension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.